Barclays PLC (BCS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BCS SEC filings page.
Barclays PLC (BCS) reported $14.9B in revenue for fiscal year 2025, up 11.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Barclays PLC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Barclays PLC earned a return on assets of 0.5% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.4% the prior year. Earnings ranks banks on that return over three years, and Barclays PLC scores 22/100 among other banks.
Barclays PLC reported revenue of $14.9B in fiscal year 2025, against $13.4B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Barclays PLC scores 52/100 among other banks.
Barclays PLC funded 5.0% of its assets with shareholders' equity at the end of fiscal year 2025, holding $104.6B of equity against $2.1T of assets. Capital ranks banks on that cushion, and Barclays PLC scores 3/100 among other banks.
Not available for Barclays PLC, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Not available for Barclays PLC, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Barclays PLC reported net income of $9.6B in fiscal year 2025, against $7.9B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Barclays PLC scores 75/100 among other banks.
Barclays PLC passes 6 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Key Financial Metrics
Earnings & Revenue
Barclays PLC generated $14.9B in revenue in fiscal year 2025. This represents an increase of 11.4% from the prior year.
Barclays PLC reported $9.6B in net income in fiscal year 2025. This represents an increase of 22.1% from the prior year.
Barclays PLC earned $0.57 per diluted share (EPS) in fiscal year 2025. This represents an increase of 30.5% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Barclays PLC held $344.9B in cash as of fiscal year 2025; no long-term debt figure is on record for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Barclays PLC's net profit margin was 64.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.7 percentage points from the prior year.
Barclays PLC's ROE was 9.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.4 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Barclays PLC spent $3.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 36.7% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
BCS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.9B+11.4% | $13.4B+5.4% | $12.7B+10.9% | $11.5B-13.0% | $13.2B+13.2% | $11.6B-2.6% | $12.0B+6.7% | $11.2B | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | $30.5B+31.9% | $23.1B-11.6% | $26.2B+4.2% | $25.1B-1.0% | $25.4B+7.7% | $23.5B-21.3% | $29.9B |
| EBITDA | N/A | N/A | N/A | N/A | $33.3B+30.6% | $25.5B-9.5% | $28.2B+5.5% | $26.7B-1.2% | $27.0B+7.7% | $25.1B-20.8% | $31.7B |
| Interest Expense | $29.2B-8.3% | $31.8B+11.5% | $28.5B+176.9% | $10.3B+140.8% | $4.3B-17.0% | $5.2B-35.8% | $8.0B+14.8% | $7.0B+36.5% | $5.1B+3.7% | $4.9B+0.1% | $4.9B |
| Income Tax | $2.6B+18.1% | $2.2B+39.5% | $1.6B+25.3% | $1.3B-18.3% | $1.5B+86.2% | $825.2M-38.0% | $1.3B+14.5% | $1.2B-58.4% | $2.8B+128.2% | $1.2B-27.7% | $1.7B |
| Net Income | $9.6B+22.1% | $7.9B+17.8% | $6.7B-6.4% | $7.2B-24.3% | $9.5B+190.6% | $3.3B-25.1% | $4.3B+44.9% | $3.0Bn/m | -$1.5B-158.5% | $2.6Bn/m | -$72.3M |
| EPS (Basic) | $0.59+30.7% | $0.45+27.7% | $0.35-5.1% | $0.37-24.5% | $0.49+310.0% | $0.12-36.6% | $0.19+58.1% | $0.12 | -$0.14 | $12.83 | -$2.80 |
| EPS (Diluted) | $0.57+30.5% | $0.44+27.1% | $0.34-4.8% | $0.36-25.1% | $0.48+309.0% | $0.12-37.2% | $0.19+59.4% | $0.12 | -$0.14 | $12.71 | -$2.80 |
| Diluted Shares (Avg) | 14.60B-4.4% | 15.27B-3.9% | 15.89B-5.8% | 16.87B-3.2% | 17.42B-1.4% | 17.67B+1.1% | 17.48B+0.6% | 17.38B | 17.28B | 17.04B | 17.05B |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses.
BCS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1T+9.2% | $1.9T+1.0% | $1.9T+3.0% | $1.8T-2.2% | $1.9T+1.4% | $1.8T+21.9% | $1.5T+4.6% | $1.4T-5.7% | $1.5T+2.4% | $1.5T-9.4% | $1.7T |
| Cash & Equivalents | $344.9B+16.9% | $295.0B-6.7% | $316.0B-6.1% | $336.7B-3.8% | $349.9B+21.9% | $287.1B+29.9% | $221.1B-10.6% | $247.3B-1.7% | $251.5B+41.5% | $177.8B-16.3% | $212.5B |
| Goodwill | $5.9B+6.6% | $5.6B+4.7% | $5.3B+12.7% | $4.7B-10.1% | $5.3B-1.1% | $5.3B+2.8% | $5.2B+3.8% | $5.0B-5.5% | $5.3B-44.7% | $9.5B-21.4% | $12.1B |
| Total Liabilities | $2.0T+8.9% | $1.8T+1.1% | $1.8T+2.7% | $1.7T-1.7% | $1.8T+1.2% | $1.8T+22.9% | $1.4T+4.5% | $1.4T-5.5% | $1.4T+2.5% | $1.4T-9.4% | $1.6T |
| Total Equity | $104.6B+16.3% | $89.9B-0.9% | $90.7B+10.0% | $82.5B-11.5% | $93.2B+3.7% | $89.9B+5.1% | $85.5B+7.1% | $79.8B-7.7% | $86.5B+8.0% | $80.0B-9.3% | $88.2B |
| Retained Earnings | $79.7B+13.6% | $70.2B+2.5% | $68.5B+7.3% | $63.8B-6.4% | $68.2B+9.6% | $62.2B+6.0% | $58.7B+5.7% | $55.5B+48.9% | $37.3B-1.1% | $37.7B-17.7% | $45.7B |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
BCS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $25.2B+182.9% | $8.9Bn/m | -$1.2B-103.2% | $36.5B-44.7% | $66.0B-15.9% | $78.6Bn/m | -$666.1M-105.7% | $11.7B-85.7% | $82.1B+489.9% | $13.9B-38.4% | $22.6B |
| Depreciation & Amortization | $2.4B+10.0% | $2.2B-20.6% | $2.7B+26.8% | $2.2B-23.0% | $2.8B+18.3% | $2.4B+17.5% | $2.0B+25.3% | $1.6B-4.1% | $1.7B+7.9% | $1.6B-13.2% | $1.8B |
| Investing Cash Flow | $2.1Bn/m | -$22.4Bn/m | -$29.8Bn/m | -$26.2B-554.1% | $5.8Bn/m | -$25.1Bn/m | -$31.8B-2098.0% | $1.6B-66.4% | $4.7B-89.5% | $45.3Bn/m | -$9.7B |
| Financing Cash Flow | $3.0B+209.0% | $981.6Mn/m | -$1.8B-310.6% | $840.6M+481.9% | $144.5M-96.1% | $3.7B+307.7% | $915.6Mn/m | -$8.7B-766.3% | $1.3Bn/m | -$1.6Bn/m | -$846.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1.7B+7.1% | $1.6B-27.1% | $2.2B |
| Share Buybacks | $3.0B+36.7% | $2.2B+37.6% | $1.6B-12.0% | $1.8B+12.4% | $1.6B | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.
BCS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | N/A | 231.5% | 198.6% | 219.0% | 224.1% | N/A | N/A | N/A |
| Net Margin | 64.5%+5.7pp | 58.9%+6.2pp | 52.7%-9.8pp | 62.4%-9.4pp | 71.8%+43.9pp | 28.0%-8.4pp | 36.4%+9.6pp | 26.8% | N/A | N/A | N/A |
| Return on Equity | 9.2%+0.4pp | 8.8%+1.4pp | 7.4%-1.3pp | 8.7%-1.5pp | 10.2%+6.5pp | 3.6%-1.5pp | 5.1%+1.3pp | 3.8%+5.5pp | -1.7%-4.9pp | 3.2%+3.3pp | -0.1% |
| Return on Assets | 0.5%0.0pp | 0.4%+0.1pp | 0.4%0.0pp | 0.4%-0.1pp | 0.5%+0.3pp | 0.2%-0.1pp | 0.3%+0.1pp | 0.2%+0.3pp | -0.1%-0.3pp | 0.2%+0.2pp | 0.0% |
| Liabilities-to-Equity | 18.85-1.3x | 20.13+0.4x | 19.74-1.4x | 21.15+2.1x | 19.03-0.5x | 19.49+2.8x | 16.68-0.4x | 17.10+0.4x | 16.70-0.9x | 17.600.0x | 17.62 |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.01 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Barclays PLC BCS | FY2025 | $14.9B | $9.6B | 64.5% | $75.3B | 38/100 |
| ING Groep N.V. ING | FY2025 | $30.1B | $9.8B | 32.4% | $94.9B | 39/100 |
| Canadian Imperial Bank of Commerce CM | FY2025 | $20.8B | $6.0B | 28.9% | $104.4B | 43/100 |
| Bank of Nova Scotia BNS | FY2025 | $26.9B | $5.6B | 20.6% | $114.4B | 38/100 |
| Bank of Montreal BMO | FY2025 | $25.9B | $6.2B | 24.0% | $118.5B | 34/100 |
Where Barclays PLC Ranks
Frequently Asked Questions
What is Barclays PLC's annual revenue?
Barclays PLC (BCS) reported $14.9B in total revenue for fiscal year 2025. This represents a 11.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Barclays PLC's revenue growing?
Barclays PLC (BCS) revenue grew by 11.4% year-over-year, from $13.4B to $14.9B in fiscal year 2025.
Is Barclays PLC profitable?
Yes, Barclays PLC (BCS) reported a net income of $9.6B in fiscal year 2025, with a net profit margin of 64.5%.
What is Barclays PLC's net profit margin?
Barclays PLC (BCS) had a net profit margin of 64.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Barclays PLC's return on equity (ROE)?
Barclays PLC (BCS) has a return on equity of 9.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Barclays PLC's operating cash flow?
Barclays PLC (BCS) generated $25.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Barclays PLC's total assets?
Barclays PLC (BCS) had $2.1T in total assets as of fiscal year 2025, including both current and long-term assets.
What is Barclays PLC's liabilities-to-equity ratio?
Barclays PLC (BCS) had a liabilities-to-equity ratio of 18.85 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Barclays PLC's return on assets (ROA)?
Barclays PLC (BCS) had a return on assets of 0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Barclays PLC's P/E ratio?
Barclays PLC (BCS) trades at 7.8x earnings, its market capitalization divided by $9.6B net income, FY2025. The market capitalization is $75.3B as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Barclays PLC's price-to-sales ratio?
Barclays PLC (BCS) trades at 5.0x sales, its market capitalization divided by $14.9B revenue, FY2025. The market capitalization is $75.3B as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Barclays PLC's Piotroski F-Score?
Barclays PLC (BCS) has a Piotroski F-Score of 6 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
How financially healthy is Barclays PLC?
Barclays PLC (BCS) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Barclays PLC it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.